title: Species specificity of anticoagulant activity of activated human protein C: involvement of factor V as well as protein S.
abstract: Activated protein C (APC) possesses species specificity in its anticoagulant activity. Human APC exerts only weak activity in rat plasma compared with that in human plasma. The present study was undertaken to estimate the difference in interaction of human and rat factors with human APC and to assess the cause of the species specificity. Human or rat protein S (PS), factor V, or factor VIII was used to supplement human plasma depleted of each respective factor, and the anticoagulant activity of human APC was measured in term of the elongation of activated partial thromboplastin time (APTT). The activity of human APC in rat PS- or factor V-supplemented plasma was weaker than that in the human PS- or factor V-supplemented plasma. Furthermore, using purified human and rat factor V, human APC showed weaker inactivation of rat factor V than human factor V. Equal anticoagulant activity was observed in human or rat factor VIII-supplemented plasma. And there was a little difference in the interaction of APC with its inhibitors in human or rat plasma during a few minutes of incubation as judged by measurement of residual activity by an enzyme capture assay. From these results factor V as well as PS seems to play a major role in the species specificity of APC.
authors.affiliation: Pharmaceuticals Development Research Laboratories, Teijin Ltd., Tokyo, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Katsuura
authors.forename: T
authors.initials: T
authors.lastname: Mochizuki
authors.forename: M
authors.initials: M
authors.lastname: Tamura
authors.forename: S
authors.initials: S
authors.lastname: Hoshide
authors.forename: M
authors.initials: M
authors.lastname: Kiyoki
authors.forename: T
authors.initials: T
authors.lastname: Nakagaki
authors.forename: S
authors.initials: S
authors.lastname: Miyamoto
mesh_terms: D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology*; D004353:Drug Evaluation, Preclinical; D004789:Enzyme Activation; D005069:Evaluation Studies as Topic; D005165:Factor V / Q000502:physiology*; D006801:Humans; D010314:Partial Thromboplastin Time; D011486:Protein C / Q000494:pharmacology*; D017293:Protein S / Q000502:physiology*; D051381:Rats; D013045:Species Specificity
chemical_list: D000925:Anticoagulants; D011486:Protein C; D017293:Protein S; D005165:Factor V